Pharmaceutical IPO veterans launch Columbus startup with Rev1 backing

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Having helped raise $200 million for two Cincinnati pharmaceutical startups that went public, a father-son team has returned to Central Ohio for their latest startup – which has a long road ahead as it seeks to develop a treatment for pinkeye.

Invirsa Inc. this month closed a $520,000 funding round led CincyTech with Rev1 Ventures, adding to an initial $100,000 Rev1 seed investment last year.

It’s the latest in a growing biotech focus for Rev1, which invests in and advises startups but through its history has tended more heavily toward software and medical devices.

Click here to read the complete article. Originally published November 28, 2017.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: